Hebei Mujin Biotechnology Co.,Ltd
Assessed Supplier Enterprise Certification
- Assessed
Supplier - 6th
years
Assessed Supplier Enterprise Certification
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Trading Company
Tel: +86 15028179772
Mobile: +86 15028179772
Tel: +86 15028179772
Fax:
Province/state: Hebei
City: shijiazhuang
Street: room 1401,A building,Enjoy city,shijiazhuang city,hebei province,China
MaxCard:
Ms.betty Ms.mayCAS NO.1270138-40-3
comestic(1-22)Kilogram
NSI-189 is an investigational drug being developed by Neuralstem Inc., a biopharmaceutical company.
NSI-189 is a small molecule in clinical development for major depressive disorder (MDD) and in preclinical development for Angelman syndrome, irradiation-induced cognitive impairment, Type 1 and Type 2 diabetes, and stroke.
NSI-189 was studied in phase I and II clinical trials for the treatment of major depressive disorder. As of July 2017, NSI-189 has failed to meet effectiveness outcomes for depression in phase II trials.
Product details
| CAS: | 1270138-40-3 |
| MF: | C22H30N4O |
| MW: | 366.5 |
| EINECS: | 1592732-453-0 |
| Product Categories: | Inhibitors;API |
| Mol File: | 1270138-40-3.mol |
| NSI-189 Chemical Properties |
| Boiling point | 534.7±50.0 °C(Predicted) |
| density | 1.134±0.06 g/cm3(Predicted) |
| storage temp. | -20°C |
| solubility | Soluble in DMSO |
| pka | 6.18±0.10(Predicted) |
| form | A crystalline solid |
| λmax | 254 nm |
| InChI | InChI=1S/C22H30N4O/c1-18(2)10-12-24-21-20(9-6-11-23-21)22(27)26-15-13-25(14-16-26)17-19-7-4-3-5-8-19/h3-9,11,18H,10,12-17H2,1-2H3,(H,23,24) |
| InChIKey | DYTOQURYRYYNOR-UHFFFAOYSA-N |
| SMILES | C(C1=CC=CN=C1NCCC(C)C)(N1CCN(CC2=CC=CC=C2)CC1)=O |
Company Profile
Why choose us